NL8702234A - Verbeteringen aan of met betrekking tot organische verbindingen. - Google Patents

Verbeteringen aan of met betrekking tot organische verbindingen. Download PDF

Info

Publication number
NL8702234A
NL8702234A NL8702234A NL8702234A NL8702234A NL 8702234 A NL8702234 A NL 8702234A NL 8702234 A NL8702234 A NL 8702234A NL 8702234 A NL8702234 A NL 8702234A NL 8702234 A NL8702234 A NL 8702234A
Authority
NL
Netherlands
Prior art keywords
pro
injection
dosing unit
infusion
dose
Prior art date
Application number
NL8702234A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868623823A external-priority patent/GB8623823D0/en
Priority claimed from GB868628741A external-priority patent/GB8628741D0/en
Priority claimed from GB878707551A external-priority patent/GB8707551D0/en
Priority claimed from GB878715678A external-priority patent/GB8715678D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8702234A publication Critical patent/NL8702234A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8702234A 1986-10-03 1987-09-18 Verbeteringen aan of met betrekking tot organische verbindingen. NL8702234A (nl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB868623823A GB8623823D0 (en) 1986-10-03 1986-10-03 Therapeutic lysis of fibrin blood clots
GB8623823 1986-10-03
GB8628741 1986-12-02
GB868628741A GB8628741D0 (en) 1986-12-02 1986-12-02 Therapeutic lysis of fibrin blood clots
GB878707551A GB8707551D0 (en) 1987-03-30 1987-03-30 Therapeutic lysis of fibrin blood clots
GB8707551 1987-03-30
GB878715678A GB8715678D0 (en) 1987-07-03 1987-07-03 Therapeutic lysis of fibrin blood clots
GB8715678 1987-07-03

Publications (1)

Publication Number Publication Date
NL8702234A true NL8702234A (nl) 1988-05-02

Family

ID=27449820

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8702234A NL8702234A (nl) 1986-10-03 1987-09-18 Verbeteringen aan of met betrekking tot organische verbindingen.

Country Status (19)

Country Link
KR (1) KR960002738B1 (enExample)
AU (1) AU7932587A (enExample)
BE (1) BE1002058A4 (enExample)
CA (1) CA1323300C (enExample)
CH (1) CH678599A5 (enExample)
DE (1) DE3731776A1 (enExample)
DK (1) DK519287A (enExample)
FI (1) FI874320L (enExample)
FR (1) FR2605225B1 (enExample)
GR (1) GR871528B (enExample)
HU (1) HUT47032A (enExample)
IL (1) IL84061A0 (enExample)
IT (1) IT1230114B (enExample)
LU (1) LU87007A1 (enExample)
MY (1) MY101943A (enExample)
NL (1) NL8702234A (enExample)
NO (1) NO874143L (enExample)
PT (1) PT85848B (enExample)
SE (1) SE466531B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.

Also Published As

Publication number Publication date
NO874143D0 (no) 1987-10-01
IT8748444A0 (it) 1987-10-02
BE1002058A4 (fr) 1990-06-12
FI874320A7 (fi) 1988-04-04
MY101943A (en) 1992-02-15
IT1230114B (it) 1991-10-07
SE8703788L (sv) 1988-04-04
KR880004821A (ko) 1988-06-27
DK519287D0 (da) 1987-10-02
LU87007A1 (fr) 1988-05-03
AU7932587A (en) 1988-04-14
GR871528B (en) 1988-02-23
KR960002738B1 (ko) 1996-02-26
FR2605225A1 (fr) 1988-04-22
PT85848B (en) 1990-01-12
CH678599A5 (enExample) 1991-10-15
DK519287A (da) 1988-04-04
FI874320A0 (fi) 1987-10-01
SE8703788D0 (sv) 1987-10-01
CA1323300C (en) 1993-10-19
FR2605225B1 (fr) 1994-02-04
PT85848A (en) 1987-11-01
IL84061A0 (en) 1988-03-31
HUT47032A (en) 1989-01-30
FI874320L (fi) 1988-04-04
SE466531B (sv) 1992-03-02
DE3731776A1 (de) 1988-05-05
NO874143L (no) 1988-04-05

Similar Documents

Publication Publication Date Title
Phillips et al. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model
JP2820699B2 (ja) 血栓溶解剤
US5055295A (en) Lysis of fibrin blood clots with urokinase and pro-urokinase
JPH0273022A (ja) 組織プラスミノーゲン活性化因子を用いた薬学的製剤
JP2688603B2 (ja) 血栓溶解剤
NL8702234A (nl) Verbeteringen aan of met betrekking tot organische verbindingen.
US8987190B2 (en) Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin
US9211317B2 (en) Method of using prourokinase in facilitated percutaneous coronary intervention in patients with acute myocardial infarction
GB2197195A (en) Urokinase compositions for treating thrombosis
CA1303987C (en) Pharmaceutical composition having thrombolytic activity
WO1992022202A1 (en) Thrombolytic and perfluorochemical treatment for myocardial infraction
JP2783367B2 (ja) ヘパリン含有製剤
Onoyama et al. Use of recombinant tissue‐type plasminogen activator to treat massive pulmonary embolism after cesarean section: a case report
PT92073B (pt) Processo para a preparacao duma composicao farmaceutica util para melhorar a disfuncao miocardica pos-isquemica
JP2002530352A (ja) 鎌状赤血球疾患およびサラセミアの処置方法
US5174994A (en) Pharmaceutical composition having thrombolytic activity
WO2005074979A1 (fr) Utilisation de la prourokinase pour le traitement du syndrome pulmonaire thrombo-embolique ou de l'occlusion de l'artere centrale de la retine
JPH11199508A (ja) 臓器不全治療剤
Walsh Tissue Plasminogen Activator-Based Thrombolytic Agents
GB2217601A (en) Pharmaceutical combinations for the treatment of thrombotic disorders
EP0332346A2 (en) Pharmaceutical combinations containing a piperidinylcyclopentylheptenoic acid derivative
HK1196289B (en) Medicine for treatment and/or improvement of sepsis

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: VASCULAR LABORATORY INC.

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed